{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:42:35Z","timestamp":1782963755611,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973387"],"award-info":[{"award-number":["81973387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00228-021-03215-9","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:04:39Z","timestamp":1652173479000},"page":"1261-1272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients"],"prefix":"10.1007","volume":"78","author":[{"given":"Xi-Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-4792","authenticated-orcid":false,"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"issue":"7","key":"3215_CR1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1681\/ASN.2014060588","volume":"26","author":"PF Halloran","year":"2015","unstructured":"Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar ID, Merino Lopez M et al (2015) Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol 26(7):1711\u20131720. https:\/\/doi.org\/10.1681\/ASN.2014060588","journal-title":"J Am Soc Nephrol"},{"key":"3215_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.chroma.2018.03.010","volume":"1547","author":"H Bittersohl","year":"2018","unstructured":"Bittersohl H, Schniedewind B, Christians U, Luppa PB (2018) A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. J Chromatogr A 1547:45\u201352. https:\/\/doi.org\/10.1016\/j.chroma.2018.03.010","journal-title":"J Chromatogr A"},{"issue":"4","key":"3215_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-j","volume":"13","author":"SL Schreiber","year":"1992","unstructured":"Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13(4):136\u2013142. https:\/\/doi.org\/10.1016\/0167-5699(92)90111-j","journal-title":"Immunol Today"},{"issue":"6","key":"3215_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2165\/00003495-199754060-00009","volume":"54","author":"CM Spencer","year":"1997","unstructured":"Spencer CM, Goa KL, Tacrolimus GJC (1997) An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54(6):925\u2013975. https:\/\/doi.org\/10.2165\/00003495-199754060-00009","journal-title":"Drugs"},{"issue":"6","key":"3215_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","volume":"17","author":"AW Thomson","year":"1995","unstructured":"Thomson AW, Bonham CA, Zeevi A (1995) Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit 17(6):584\u2013591. https:\/\/doi.org\/10.1097\/00007691-199512000-00007","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3215_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","volume":"29","author":"R Venkataramanan","year":"1995","unstructured":"Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V et al (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29(6):404\u2013430. https:\/\/doi.org\/10.2165\/00003088-199529060-00003","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3215_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","volume":"31","author":"P Wallemacq","year":"2009","unstructured":"Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A et al (2009) Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 31(2):139\u2013152. https:\/\/doi.org\/10.1097\/FTD.0b013e318198d092","journal-title":"Ther Drug Monit"},{"key":"3215_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2017.12.005","volume":"129","author":"P Marquet","year":"2018","unstructured":"Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C et al (2018) Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients. Pharmacol Res 129:84\u201394. https:\/\/doi.org\/10.1016\/j.phrs.2017.12.005","journal-title":"Pharmacol Res"},{"key":"3215_CR9","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1517\/14656566.2015.1056734","volume":"16","author":"J Bamoulid","year":"2015","unstructured":"Bamoulid J, Staeck O, Halleck F, D\u00fcrr M, Paliege A, Lachmann N et al (2015) Advances in pharmacotherapy to treat kidney transplant rejection. Expert Opin Pharmacother 16:1627\u20131648","journal-title":"Expert Opin Pharmacother"},{"key":"3215_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","volume":"11","author":"K Boudjema","year":"2011","unstructured":"Boudjema K, Camus C, Saliba F, Calmus Y, Salam\u00e9 E, Pageaux G et al (2011) Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant 11:965\u2013976","journal-title":"Am J Transplant"},{"issue":"1","key":"3215_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4416","volume":"33","author":"S Bahmany","year":"2019","unstructured":"Bahmany S, de Wit LEA, Hesselink DA, van Gelder T, Shuker NM, Baan C et al (2019) Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 33(1):e4416. https:\/\/doi.org\/10.1002\/bmc.4416","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"3215_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/pgs.10.43","volume":"11","author":"A Capron","year":"2010","unstructured":"Capron A, Mourad M, De Meyer M, De Pauw L, Eddour DC, Latinne D et al (2010) CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. Pharmacogenomics 11(5):703\u2013714. https:\/\/doi.org\/10.2217\/pgs.10.43","journal-title":"Pharmacogenomics"},{"issue":"1","key":"3215_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","volume":"25","author":"A Capron","year":"2012","unstructured":"Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P (2012) Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int 25(1):41\u201347. https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01365.x","journal-title":"Transpl Int"},{"issue":"1","key":"3215_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.ftd.0000183385.27394.e7","volume":"28","author":"U Christians","year":"2006","unstructured":"Christians U, Strom T, Zhang YL, Steudel W, Schmitz V, Trump S et al (2006) Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics. Ther Drug Monit 28(1):39\u201344. https:\/\/doi.org\/10.1097\/01.ftd.0000183385.27394.e7","journal-title":"Ther Drug Monit"},{"issue":"5","key":"3215_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40262-018-0717-7","volume":"58","author":"C Tron","year":"2019","unstructured":"Tron C, Lemaitre F, Verstuyft C, Petitcollin A, Verdier MC, Bellissant E (2019) Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation. Clin Pharmacokinet 58(5):593\u2013613. https:\/\/doi.org\/10.1007\/s40262-018-0717-7","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3215_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cpt.113","volume":"98","author":"KA Birdwell","year":"2015","unstructured":"Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W et al (2015) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther 98(1):19\u201324. https:\/\/doi.org\/10.1002\/cpt.113","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3215_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FTD.0b013e31811f319b","volume":"29","author":"AE Mendonza","year":"2007","unstructured":"Mendonza AE, Zahir H, Gohh RY, Akhlaghi F (2007) Tacrolimus in diabetic kidney transplant recipients: pharmacokinetics and application of a limited sampling strategy. Ther Drug Monit 29(4):391\u2013398. https:\/\/doi.org\/10.1097\/FTD.0b013e31811f319b","journal-title":"Ther Drug Monit"},{"issue":"3","key":"3215_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.ftd.0000211810.19935.44","volume":"28","author":"LS Ting","year":"2006","unstructured":"Ting LS, Villeneuve E, Ensom MH (2006) Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants. Ther Drug Monit 28(3):419\u2013430. https:\/\/doi.org\/10.1097\/01.ftd.0000211810.19935.44","journal-title":"Ther Drug Monit"},{"issue":"11","key":"3215_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00228-007-0354-9","volume":"63","author":"RA Op den Buijsch","year":"2007","unstructured":"Op den Buijsch RA, van de Plas A, Stolk LM, Christiaans MH, van Hooff JP, Undre NA et al (2007) Evaluation of limited sampling strategies for tacrolimus. Eur J Clin Pharmacol 63(11):1039\u20131044. https:\/\/doi.org\/10.1007\/s00228-007-0354-9","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3215_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/s0272-6386(00)70013-8","volume":"35","author":"KM Wong","year":"2000","unstructured":"Wong KM, Shek CC, Chau KF, Li CS (2000) Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. Am J Kidney Dis 35(4):660\u2013666. https:\/\/doi.org\/10.1016\/s0272-6386(00)70013-8","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3215_CR21","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1016\/j.transproceed.2005.11.055","volume":"37","author":"YH Chen","year":"2005","unstructured":"Chen YH, Zheng KL, Chen LZ, Dai YP, Fei JG, Qiu J et al (2005) Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients. Transplant Proc 37(10):4246\u20134250. https:\/\/doi.org\/10.1016\/j.transproceed.2005.11.055","journal-title":"Transplant Proc"},{"issue":"2","key":"3215_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1432-2277.2007.00584.x","volume":"21","author":"CY Cheung","year":"2008","unstructured":"Cheung CY, van der Heijden J, Hoogtanders K, Christiaans M, Liu YL, Chan YH et al (2008) Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transpl Int 21(2):140\u2013145. https:\/\/doi.org\/10.1111\/j.1432-2277.2007.00584.x","journal-title":"Transpl Int"},{"issue":"5","key":"3215_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/ftd.0000000000000765","volume":"42","author":"B Chen","year":"2020","unstructured":"Chen B, Lu JQ, Shao K, Zhai XH, An HM, Shi HQ et al (2020) Establishment of a liquid chromatography-tandem mass spectrometry method for the determination of immunosuppressant levels in the peripheral blood mononuclear cells of Chinese renal transplant recipients. Ther Drug Monit 42(5):686\u2013694. https:\/\/doi.org\/10.1097\/ftd.0000000000000765","journal-title":"Ther Drug Monit"},{"issue":"10","key":"3215_CR24","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1016\/j.transproceed.2010.09.155","volume":"42","author":"ZY Li","year":"2010","unstructured":"Li ZY, Yan CL, Yan R, Feng ZR (2010) Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. Transplant Proc 42(10):4534\u20134537. https:\/\/doi.org\/10.1016\/j.transproceed.2010.09.155","journal-title":"Transplant Proc"},{"issue":"2","key":"3215_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jcla.20299","volume":"23","author":"B Chen","year":"2009","unstructured":"Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W (2009) Detection of C1236T, G2677T\/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR. J Clin Lab Anal 23(2):110\u2013116. https:\/\/doi.org\/10.1002\/jcla.20299","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"3215_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2125.2010.03815.x","volume":"71","author":"KA Barraclough","year":"2011","unstructured":"Barraclough KA, Isbel NM, Kirkpatrick CM, Lee KJ, Taylor PJ, Johnson DW et al (2011) Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients. Br J Clin Pharmacol 71(2):207\u2013223. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03815.x","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3215_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","volume":"43","author":"CE Staatz","year":"2004","unstructured":"Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43(10):623\u2013653. https:\/\/doi.org\/10.2165\/00003088-200443100-00001","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"3215_CR28","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/17425255.2017.1395413","volume":"13","author":"LM Andrews","year":"2017","unstructured":"Andrews LM, Li Y, De Winter BCM, Shi YY, Baan CC, Van Gelder T et al (2017) Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Expert Opin Drug Metab Toxicol 13(12):1225\u20131236. https:\/\/doi.org\/10.1080\/17425255.2017.1395413","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"3215_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/ftd.0000000000000351","volume":"38","author":"NA Stienstra","year":"2016","unstructured":"Stienstra NA, Sikma MA, van Dapperen AL, de Lange DW, van Maarseveen EM (2016) Development of a simple and rapid method to measure the free fraction of tacrolimus in plasma using ultrafiltration and LC-MS\/MS. Ther Drug Monit 38(6):722\u2013727. https:\/\/doi.org\/10.1097\/ftd.0000000000000351","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3215_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153491","volume":"11","author":"SS Han","year":"2016","unstructured":"Han SS, Yang SH, Kim MC, Cho JY, Min SI, Lee JP et al (2016) Monitoring the intracellular tacrolimus concentration in kidney transplant recipients with stable graft function. PLoS ONE 11(4):e0153491. https:\/\/doi.org\/10.1371\/journal.pone.0153491","journal-title":"PLoS ONE"},{"issue":"6","key":"3215_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clinbiochem.2014.12.018","volume":"48","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Blanchet B, Latournerie M, Antignac M, Houssel-Debry P, Verdier MC et al (2015) Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. Clin Biochem 48(6):406\u2013411. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.12.018","journal-title":"Clin Biochem"},{"issue":"8","key":"3215_CR32","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1373\/clinchem.2005.050047","volume":"51","author":"LK Kamdem","year":"2005","unstructured":"Kamdem LK, Streit F, Zanger UM, Brockm\u00f6ller J, Oellerich M, Armstrong VW et al (2005) Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin Chem 51(8):1374\u20131381. https:\/\/doi.org\/10.1373\/clinchem.2005.050047","journal-title":"Clin Chem"},{"issue":"1","key":"3215_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.transproceed.2009.11.028","volume":"42","author":"J Larriba","year":"2010","unstructured":"Larriba J, Imperiali N, Groppa R, Giordani C, Algranatti S, Redal MA (2010) Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients. Transplant Proc 42(1):257\u2013259. https:\/\/doi.org\/10.1016\/j.transproceed.2009.11.028","journal-title":"Transplant Proc"},{"issue":"5","key":"3215_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1046\/j.1365-2036.2002.01238.x","volume":"16","author":"RJ Farrell","year":"2002","unstructured":"Farrell RJ, Menconi MJ, Keates AC, Kelly CP (2002) P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes. Aliment Pharmacol Ther 16(5):1021\u20131031. https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01238.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"3215_CR35","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/ftd.0000000000000255","volume":"38","author":"N Picard","year":"2016","unstructured":"Picard N, Bergan S, Marquet P, van Gelder T, Wallemacq P, Hesselink DA et al (2016) Pharmacogenetic biomarkers predictive of the pharmacokinetics and pharmacodynamics of immunosuppressive drugs. Ther Drug Monit 38(Suppl 1):S57\u2013S69. https:\/\/doi.org\/10.1097\/ftd.0000000000000255","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3215_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/11317550-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. Clin Pharmacokinet 49(4):207\u2013221. https:\/\/doi.org\/10.2165\/11317550-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3215_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2174\/138945011795378487","volume":"12","author":"V Haufroid","year":"2011","unstructured":"Haufroid V (2011) Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition. Curr Drug Targets 12(5):631\u2013646. https:\/\/doi.org\/10.2174\/138945011795378487","journal-title":"Curr Drug Targets"},{"issue":"3","key":"3215_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/11317350-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clin Pharmacokinet 49(3):141\u2013175. https:\/\/doi.org\/10.2165\/11317350-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"3215_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/FTD.0b013e31828c1581","volume":"35","author":"R Vafadari","year":"2013","unstructured":"Vafadari R, Bouamar R, Hesselink DA, Kraaijeveld R, van Schaik RH, Weimar W et al (2013) Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. Ther Drug Monit 35(4):459\u2013465. https:\/\/doi.org\/10.1097\/FTD.0b013e31828c1581","journal-title":"Ther Drug Monit"},{"key":"3215_CR40","first-page":"439","volume":"37","author":"I Mahmood","year":"1999","unstructured":"Mahmood I, Miller R (1999) Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis. Int J Clin Pharmacol Ther 37:439\u2013445","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03215-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03215-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T07:03:55Z","timestamp":1657782235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03215-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3215"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03215-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the ethical standards of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Ruijin Hospital, which is affiliated with the Shanhai Jiao-Tong University School of Medicine. All the patients who participated in the study provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The online version of this article contains supplementary material, which is available to authorized users.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Electronic supplementary material"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}